Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1Pituitary Neoplasms 1Osteoporosis 1Infertility, Female 1Fractures, Bone 1Breast Neoplasms 1

Interventions

Metformin 139Clomiphene 44Letrozole 36Inositol 28Folic Acid 17Exercise 17Progesterone 16Ethinyl Estradiol 13Caloric Restriction 13drospirenone and ethinyl estradiol combination 12Estradiol 12Contraceptives, Oral 11cetrorelix 10Pioglitazone 10High-Intensity Interval Training 10Chorionic Gonadotropin 10Triptorelin Pamoate 9Tablets 9Spironolactone 8Diet 8Cholecalciferol 8Vitamin D 7Thioctic Acid 7Surveys and Questionnaires 7Menotropins 7Liraglutide 7Gonadotropins 7Acupuncture Therapy 7drospirenone 6Ovidrel 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Polycystic Ovary Syndrome × Hormone Replacement Therapy × Clear all
NCT05189873 2022-01-13

GnRH Agonist Plus Hormone Replacement Therapy vs Hormone Replacement Therapy on IVF Outcomes

Tehran University of Medical Sciences

Phase 3 Completed
128 enrolled

Infertility, Female, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡